X
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
11
PharmaCompass offers a list of Ofatumumab API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ofatumumab manufacturer or Ofatumumab supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ofatumumab manufacturer or Ofatumumab supplier.
PharmaCompass also assists you with knowing the Ofatumumab API Price utilized in the formulation of products. Ofatumumab API Price is not always fixed or binding as the Ofatumumab Price is obtained through a variety of data sources. The Ofatumumab Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A arzerra manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of arzerra, including repackagers and relabelers. The FDA regulates arzerra manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. arzerra API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A arzerra supplier is an individual or a company that provides arzerra active pharmaceutical ingredient (API) or arzerra finished formulations upon request. The arzerra suppliers may include arzerra API manufacturers, exporters, distributors and traders.
click here to find a list of arzerra suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The arzerra Drug Master File in Japan (arzerra JDMF) empowers arzerra API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the arzerra JDMF during the approval evaluation for pharmaceutical products. At the time of arzerra JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of arzerra suppliers with JDMF on PharmaCompass.
arzerra Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of arzerra GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right arzerra GMP manufacturer or arzerra GMP API supplier for your needs.
A arzerra CoA (Certificate of Analysis) is a formal document that attests to arzerra's compliance with arzerra specifications and serves as a tool for batch-level quality control.
arzerra CoA mostly includes findings from lab analyses of a specific batch. For each arzerra CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
arzerra may be tested according to a variety of international standards, such as European Pharmacopoeia (arzerra EP), arzerra JP (Japanese Pharmacopeia) and the US Pharmacopoeia (arzerra USP).
Market Place
